Skip to main content

Inspection visit

Inspection

DAYSPRING OF MIAMI VALLEY HLTH CARE CENTER & REHABCMS #3661511 citation on this visit
1 citation recorded

Inspector’s narrative

What the inspector wrote

This survey cited 1 deficiency. The full statement and the facility’s plan of correction follow, verbatim from the federal record.

F 0758 Level of Harm - Minimal harm or potential for actual harm Residents Affected - Few Implement gradual dose reductions(GDR) and non-pharmacological interventions, unless contraindicated, prior to initiating or instead of continuing psychotropic medication; and PRN orders for psychotropic medications are only used when the medication is necessary and PRN use is limited. Based on medical record review, staff interview, policy review, and review of the medication information from Medscape, the facility failed to ensure a resident was free from unnecessary psychotropic medication usages when the facility failed to have an adequate indication of use for an antipsychotic medication. This affected one (#132) out of three residents reviewed for psychotropic medication usage. Facility census was 129. Findings include: Review of the medical record for Resident #132 revealed an admission date of 05/03/23. Diagnoses include unspecified head injury, concussion, repeated falls, hypertensive chronic kidney disease, depression, and restless leg syndrome (RLS). The medical record revealed Resident #132 was discharged on 05/16/23. Review of the medical record for Resident #132 revealed an admission Minimum Data Set (MDS) 3.0, dated 05/10/23, which indicated Resident #132 had severe cognitive impairment and required limited assistance with bed mobility, toileting, and transfers. The MDS indicated Resident #132 received an antipsychotic medication routinely. Review of medical record for Resident #132 revealed a physician order dated 05/05/23 for haloperidol (antipsychotic medication) 10 milligram (mg) by mouth daily at bedtime routinely for agitation. Review of medical record for Resident #132 revealed a medication administration record (MAR) for May 2023 which revealed Resident #132 received haloperidol 10 mg daily at bedtime routinely from 05/06/23 to 05/16/23 for agitation. Review of the medical record for Resident #132 revealed a behavior monitoring assessment, dated 05/06/23 at 11:28 P.M., which stated Resident #132 was agitated, anxious, had continued pacing, fighting, restless and wandering. The assessment stated staff provided one on one supervision, changed positions, removed the resident from the environment, toileted resident, and redirected resident which were all ineffective. Further review of the assessment revealed the documentation was initiated on 05/06/23 but was not completed until 05/26/23. Review of the medical record for Resident #132 revealed a nursing progress note dated 05/06/23 at 11:28 P.M., which stated Resident #132 was ordered haloperidol 10 mg by mouth daily at bedtime routinely due to agitation. (continued on next page) Any deficiency statement ending with an asterisk (*) denotes a deficiency which the institution may be excused from correcting providing it is determined that other safeguards provide sufficient protection to the patients. (See instructions.) Except for nursing homes, the findings stated above are disclosable 90 days following the date of survey whether or not a plan of correction is provided. For nursing homes, the above findings and plans of correction are disclosable 14 days following the date these documents are made available to the facility. If deficiencies are cited, an approved plan of correction is requisite to continued program participation. LABORATORY DIRECTOR'S OR PROVIDER/SUPPLIER REPRESENTATIVE'S SIGNATURE TITLE (X6) DATE FORM CMS-2567 (02/99) Previous Versions Obsolete Facility ID: If continuation sheet Page 1 of 2 Event ID: 366151 Printed: 05/15/2026 Form Approved OMB No. 0938-0391 Department of Health & Human Services Centers for Medicare & Medicaid Services STATEMENT OF DEFICIENCIES AND PLAN OF CORRECTION (X1) PROVIDER/SUPPLIER/CLIA IDENTIFICATION NUMBER: (X2) MULTIPLE CONSTRUCTION 366151 B. Wing A. Building (X3) DATE SURVEY COMPLETED 05/31/2023 NAME OF PROVIDER OR SUPPLIER STREET ADDRESS, CITY, STATE, ZIP CODE Dayspring of Miami Valley Hlth Care Center & Rehab 8001 Dayton Springfield Road Fairborn, OH 45324 For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency. (X4) ID PREFIX TAG SUMMARY STATEMENT OF DEFICIENCIES (Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0758 Level of Harm - Minimal harm or potential for actual harm Interview on 05/31/23 at 1:00 P.M. with Registered Nurse (RN) #335 stated she was the nurse who took care of Resident #132 on the evening of 05/05/23. RN #335 stated Resident #132 was very agitated, was attempting to elope and was hitting, kicking, and spitting staff. RN #335 confirmed Resident #132 did not have a diagnosis of schizophrenia, or a psychosis disorder and confirmed the haloperidol was ordered for Resident #132's agitation. Residents Affected - Few Review of facility policy titled Psychotropic: Anti-psychotic Medication Management, revised October 2017, stated residents who have not used psychotropic drugs are not to be given these drugs unless the medication is necessary to treat a specific condition as diagnosed and documented in the clinical record. The policy also stated if an anti-psychotic medication is ordered, an appropriate diagnosis will be assigned to the medication and behavior monitoring will be initiated. Review of medication information from Medscape at https://reference.medscape.com/drug/haldol-decanoate-haloperidol-342974, revealed haloperidol (Haldol) is an antipsychotic medication and is used for schizophrenia, psychosis and Tourette Disorder. Haldol has a Black Box Warnings which indicates patients with dementia-related psychosis who are treated with antipsychotic drugs are at an increased risk for death, as shown in short-term controlled trials; deaths in trials appeared to be either cardiovascular (eg, heart failure, sudden death) or infectious (eg, pneumonia) in nature. Haldol is not approved for treatment of patients with dementia-related psychosis This deficiency represents non-compliance investigated under Complaint Number OH00143160. FORM CMS-2567 (02/99) Previous Versions Obsolete Event ID: Facility ID: 366151 If continuation sheet Page 2 of 2

Reading this as a family member? Your long-term care ombudsman is a free advocate for residents and families.

Back to top

Citations

1 citation recorded*CMS

What do CMS severity letters mean?

Serious (G-L). Actual harm to a resident, or immediate jeopardy. Codes G through I indicate actual harm; J through L indicate immediate jeopardy to resident health or safety.

General (A-F). No actual harm found, or harm that is minimal. The facility must still submit a Plan of Correction. Most CMS citations land here.

Each letter combines severity with scope: how many residents the deficiency affected.

  • 0758GeneralS&S Dpotential for harm

    F758 - Medication Errors

    Implement gradual dose reductions(GDR) and non-pharmacological interventions, unless contraindicated, prior to initiating or instead of continuing psychotropic medication; and PRN orders for psychotropic medications are only used when the medication is necessary and PRN use is limited.

FAQ · About this visit

Common questions about this visit

What happened during the May 31, 2023 survey of DAYSPRING OF MIAMI VALLEY HLTH CARE CENTER & REHAB?

This was a inspection survey of DAYSPRING OF MIAMI VALLEY HLTH CARE CENTER & REHAB on May 31, 2023. The surveyor cited 1 deficiency, recorded on the federal Form 2567 statement of deficiencies.

Were any deficiencies cited at DAYSPRING OF MIAMI VALLEY HLTH CARE CENTER & REHAB on May 31, 2023?

Yes, 1 deficiency was cited, each with a CMS Scope and Severity grade. The first was: "Implement gradual dose reductions(GDR) and non-pharmacological interventions, unless contraindicated, prior to initiatin..."

What type of survey was this?

This was a inspection survey conducted by state surveyors under federal Centers for Medicare & Medicaid Services (CMS) oversight. Findings are published on CMS Care Compare.

Share this reportEmail

Next steps

Concerned about a resident’s care?Find your local ombudsman through the Eldercare Locatoror file a complaint with your state survey agency.

Researching this visit professionally?Book a 15-minute calland we will walk through what we have on file.

Data from CMS Care Compare public records. Dataset last refreshed . If you believe any information is inaccurate, report it here.